Current Issue

View Larger Image

Past Issues Adlink Subscription

ADVERTISEMENT

ADVERTISEMENT

Top Keywords

Follow GEN on Twitter

GEN news highlights: Feb 22, 2008

Investigators Uncover Structure of Bacterial Microcompartment

(Page 1 of 1)

Researchers identified proteins that play a critical role in how the carboxysome folds. The carboxysome is a protein shell that is one of the most studied microcompartments, which seems to be present in a wide variety of pathogens including bacteria.

Previously, researchers discovered the 3-D structures of hexameric carboxysome shell proteins that make up part of the carboxysome. In the current study, the investigators identified the 3-D structures of two proteins of previously unknown function, CcmL and OrfA (or CsoS4A), that assemble to form pentameric structures of the microcompartment. “Combining these pentamers with the hexamers previously elucidated gives two plausible, preliminary atomic models for the carboxysome shell,” wrote the investigators.

“A soccer ball has hexagons and 12 pentagons at the corners; the pentagons are essential to close the structure,” explains coauthor Todd O. Yeates, Ph.D., professor of chemistry and biochemistry at the University of California at Los Angeles (UCLA). “This principle of closing a structure by combining a large number of hexagons with a small number of pentagons to create a piece of curvature is apparently understood by microcompartments, in which proteins form 12 pentagons to close the structure.” 

The research was performed by scientists at UCLA, the DOE Joint Genome Institute, University of California, Berkeley, and University of Southern Mississippi. The paper is published in the February 22 issue of Science.


ADVERTISEMENT

Upcoming webinars

GEN webinars

Broadcast Dates: September 28 & 30, 2010
Wednesday, September 22, 2010
« View All Webinars »

Career center

For the latest biotech employment opportunities, start your search HERE!

« Visit the Career Center »

ADVERTISEMENT

Featured podcast

Stapled Peptides Making Progress
Gregory L. Verdine, Ph.D., Harvard College Professor and Erving Professor of Chemistry, Department of Cellular and Molecular Biology, Harvard University, and Founder and Co-Chairman, Scientific Advisory Board, Aileron Therapeutics

« Podcast Archive »